News & Media

 

Companies Continue to Take Aim at Glioblastoma, a Cancer Highlighted by the Death of Sen. John McCain
August 27  2018 – by BioSpace

AIVITA Biomedical is launching a Phase 2 trial to assess the safety and effectiveness of its cell-based immunotherapy for the treatment of an aggressive form of brain cancer, called glioblastoma multiforme.

 

FDA Approves Phase 2 Trial Testing AIVITA’s Vaccine for Aggressive Brain Cancer
July 3  2018 – by Immuno-Oncology News

AIVITA Biomedical is launching a Phase 2 trial to assess the safety and effectiveness of its cell-based immunotherapy for the treatment of an aggressive form of brain cancer, called glioblastoma multiforme.

 

AIVITA Advances Phase 2 Clinical Trial for Ovarian Cancer Vaccine
June 29  2018 – by Ovarian Cancer News Today

AIVITA Biomedical has begun to randomize patients for a Phase 2 clinical trial assessing its cell-based immunotherapy for the treatment of newly-diagnosed advanced ovarian cancer.

 

Asia Digest: China’s LendChain secures fresh funds; S Korea’s SFC backs AIVITA
June 12  2018 – by Deal Street Asia

Deal Street Asia reports on the close of AIVITA’s recent Series B financing round and backing by S. Korea’s SFC.

 

AIVITA Biomedical Raises $15 Million Series B
June 11  2018 – by Orange County Business Journal

Eighteen-month-old Aivita Biomedical is in pretty good shape for a newly formed company…

 

Dr. Hans Keirstead Speaks at Exponential Medicine 2017
November 7  2017 – by Singularity University

Dr. Hans Keirstead speaks at Exponential Medicine 2017 providing an overview of the stem cell sector and highlighting recent advancements by AIVITA Biomedical.

 

Cutting Edge Ingredients
September  2017 – by MedEsthetics Magazine

MedEsthetics Magazine covers the latest exciting new skincare products and ingredients, including the PROVOQUETM line of skincare products.

 

First Paralyzed Human Regains His Upper Body Movement After Being Treated With Stem Cells
July 4 2017 – by The Power of Ideas, Ideapod Blog

Acute spinal cord injury patient in Asterias Biotherapeutics’ SCiStar trial regains upper body movement after being treated with doses of AST-OPC1 cells.

 

Cosmeceuticals 2017
May/June 2017Wendy Lewis, PRIME International Journal of Aesthetic and Anti-Aging Medicine

Wendy Lewis takes a deep dive into the professional skin care market and what’s driving new launches and consumer demands.

 

Looking GOOD!
May/June 2017Nora Burba Trulsson and Lauren Swanson, Modern Luxury Scottsdale

Modern Luxury Scottsdale speaks with local philanthropist Vicki Vaughn to discuss her must-haves for staying gorgeous inside and out, including PROVOQUE® Eye Complex.

 

Diabetes Cure: Could You Eventually Stop Pills and Insulin
May 17, 2017 – David Nazar, PBS

Millions of people suffer from diabetes. Until now the treatment has been pills or insulin. However, scientists have made a phenomenal new discovery using stem cells to eventually cure diabetes. PBS reporter David Nazar discusses clinical trials with renowned expert Dr. Hans Keirstead.

 

Can new supplements, serum repair skin from the inside and outside?
April 03, 2017Meg Farris, WWLTV

WWLTV New Orleans speaks with dermatologist Dr. Mary Lupo about the latest in skin care and the regimen she employs at her practice, which includes the use of PROVOQUE® following laser treatment.

 

Human stem cells successfully restore the skin stem cell niche, rejuvenate skin
February 10, 2017Healio

Healio reports on a CME (continuing medical education) presentation given by AIVITA Chief Science Officer Dr. Gabriel Nistor at the 2017 South Beach Symposium. In his talk, Dr. Nistor highlighted new findings concerning the use of skin stem cell factors for skin rejuvenation.